98%
921
2 minutes
20
Tanshinone IIA (Tan IIA) is a member of the major lipophilic components abstracted from the root of Salvia miltiorrhiza Bunge and has the capacity of anti-atherosclerosis. To investigate the potential mechanism, we established an animal model by giving high fatty diet to rabbits and Tan IIA was given in different dose. Then, superoxide dismutase (SOD) activity and the malondialdehyde (MDA) level in serum were detected using spectrophotometry; cluster of differentiation 40 (CD40) expression of cellular membrane fraction of aortas and matrix metalloproteinase-2 (MMP-2) activity of total protein extract of aortas were detected by Western Blotting and Zymography, respectively. Compared with the control group, the level of MDA, the expression of CD40 and the MMP-2 activity were increased while the SOD activity was decreased significantly in model group. After Tan IIA administration, the SOD activity was significantly increased while the level of MDA was decreased; both the expression of CD40 and the activity of MMP-2 were decreased. It is suggested that Tan IIA not only inhibits the oxidation but also suppresses the inflammation in atherosclerotic lesion. Our data suggest that not only anti-oxidation but also anti-inflammation by decrease the expression of CD40 and MMP-2 activity maybe the potential mechanisms by which Tan IIA anti-atherosclerosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jep.2007.09.025 | DOI Listing |
Toxicol Res (Camb)
August 2025
Department of Urology, Shanghai University of Medicine & Health Sciences Affiliated Zhoupu Hospital, No.1500 Zhouyuan Road, Pudong New Area, Shanghai 201318, China.
Tanshinone IIA (Tan IIA), a pleiotropic bioactive natural compound, has a general anti-tumor effect, as well as in bladder cancer. However, little is known about its mechanism. This work attempts to explore the mechanism of Tan IIA promoting cuproptosis in bladder cancer cells and the effective targets.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
August 2025
Laboratory of NF-κB Signalling, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore 138673, Singapore.
Extrinsic apoptosis is initiated by signaling from death receptors, leading to the assembly of RIPK1, FADD, and caspase-8 complex. Subsequently, caspase-8 forms a filamentous structure through the oligomerization of its tandem death effector domain (tDED), resulting in caspase activation and cell death. Although the DED of FADD (DED) is homologous to the tDEDs of caspase-8 (tDED) and both oligomerize to function, the functional form of DED oligomer in extrinsic apoptosis remains unclear.
View Article and Find Full Text PDFRegen Ther
December 2025
Department of Orthopedics, XianJu People's Hospital, Zhejiang Southeast Campus of Zhejiang Provincial People's Hospital, Affiliated Xianju's Hospital, Hangzhou Medical College, Xianju, Zhejiang, 317399, China.
Background: Fibro-adipogenic progenitors (FAPs) contribute to excessive muscular fatty infiltration after rotator cuff tears (RCT), impairing shoulder function. Tanshinone IIA (Tan IIA), a major active compound from Salvia miltiorrhiza Bunge, has known anti-adipogenic effects, yet its impact on FAP adipogenesis remains unclear.
Methods: Human FAPs from rotator cuff muscles were isolated via FACS, cultured, and treated with Tan IIA.
Am J Chin Med
August 2025
State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu 210009, P. R. China.
Oxidative stress serves as a driving force for myofibroblast activation in pulmonary fibrosis (PF). As a main enzymatic source of reactive oxygen species (ROS), NADPH oxidase 4 (Nox4) plays a critical role in modulating myofibroblast activation, and has thus emerged as a potential therapeutic target for PF. Tanshinone IIA (Tan-IIA), the most abundant fat-soluble component found in the root and rhizome of Bge.
View Article and Find Full Text PDFMed Oncol
August 2025
Natural Products Chem-Bio Innovation Center, Chengdu University, Chengdu, 610106, China.
Poly ADP-ribose Polymerase (PARP) inhibitor-based targeted therapy benefits the triple-negative breast cancer (TNBC) patients with Breast cancer susceptibility genes (BRCAs) mutation. However, only about 50% BRCA-mutated TNBC patients respond to PARP inhibitor treatment and 80% TNBC patients are BRCA proficient, which limit clinical application of PARP inhibitor for TNBC treatment. Ataxia-telangiectasia mutated (ATM) is a DNA double-strand break (DSB) sensor to detect and facilitate DSB repair.
View Article and Find Full Text PDF